Overall, these data suggest that neither IL6 nor IL11 trans-signaling plays a role in NASH, which is consistent with other studies where IL6 family trans-signaling has not been detected20,21,30,31. Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.